AT220157B - Verfahren zur Herstellung neuer Ester der Nicotinsäure - Google Patents
Verfahren zur Herstellung neuer Ester der NicotinsäureInfo
- Publication number
- AT220157B AT220157B AT709059A AT709059A AT220157B AT 220157 B AT220157 B AT 220157B AT 709059 A AT709059 A AT 709059A AT 709059 A AT709059 A AT 709059A AT 220157 B AT220157 B AT 220157B
- Authority
- AT
- Austria
- Prior art keywords
- nicotinic acid
- weight
- parts
- production
- carried out
- Prior art date
Links
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title claims description 27
- 229960003512 nicotinic acid Drugs 0.000 title claims description 15
- 235000001968 nicotinic acid Nutrition 0.000 title claims description 15
- 239000011664 nicotinic acid Substances 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 8
- 150000002148 esters Chemical class 0.000 title description 9
- 238000004519 manufacturing process Methods 0.000 title description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 claims description 2
- 150000004996 alkyl benzenes Chemical class 0.000 claims description 2
- 150000008422 chlorobenzenes Chemical class 0.000 claims description 2
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- -1 nicotinic acid halide Chemical class 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229960000278 theophylline Drugs 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N Theophylline Natural products O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 3
- MSYBLBLAMDYKKZ-UHFFFAOYSA-N hydron;pyridine-3-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=CN=C1 MSYBLBLAMDYKKZ-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- VPODXHOUBDCEHN-UHFFFAOYSA-N pyridine-3-carbonyl pyridine-3-carboxylate Chemical compound C=1C=CN=CC=1C(=O)OC(=O)C1=CC=CN=C1 VPODXHOUBDCEHN-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GEPVMDINFCTKRV-UHFFFAOYSA-N 8,8-dimethyl-3H-purine-2,6-dione Chemical class CC1(N=C2NC(NC(C2=N1)=O)=O)C GEPVMDINFCTKRV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- MXRGZXBFSKSZPH-UHFFFAOYSA-N protheobromine Chemical compound O=C1N(CC(O)C)C(=O)N(C)C2=C1N(C)C=N2 MXRGZXBFSKSZPH-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 229960004559 theobromine Drugs 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- NWPRCRWQMGIBOT-UHFFFAOYSA-N 7-(2-hydroxyethyl)-1,3-dimethylpurine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CCO)C=N2 NWPRCRWQMGIBOT-UHFFFAOYSA-N 0.000 description 1
- YJVROOPRHZRFPU-UHFFFAOYSA-N CC(CN(C1=C(C(N2)=O)N(C)C=N1)C2=O)O Chemical compound CC(CN(C1=C(C(N2)=O)N(C)C=N1)C2=O)O YJVROOPRHZRFPU-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT709059A AT220157B (de) | 1959-09-30 | 1959-09-30 | Verfahren zur Herstellung neuer Ester der Nicotinsäure |
| FR847117A FR814M (en, 2012) | 1959-09-30 | 1960-12-16 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT709059A AT220157B (de) | 1959-09-30 | 1959-09-30 | Verfahren zur Herstellung neuer Ester der Nicotinsäure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT220157B true AT220157B (de) | 1962-03-12 |
Family
ID=3592618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT709059A AT220157B (de) | 1959-09-30 | 1959-09-30 | Verfahren zur Herstellung neuer Ester der Nicotinsäure |
Country Status (2)
| Country | Link |
|---|---|
| AT (1) | AT220157B (en, 2012) |
| FR (1) | FR814M (en, 2012) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3037391A1 (de) * | 1980-10-03 | 1982-05-19 | King Consult GmbH, 5000 Köln | Ester von 7-hydroxyalkyl-1,3-dimethylxanthinen, verfahren zu ihrer herstellung und ihre verwendung als lipidsenkende mittel |
-
1959
- 1959-09-30 AT AT709059A patent/AT220157B/de active
-
1960
- 1960-12-16 FR FR847117A patent/FR814M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR814M (en, 2012) | 1961-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1445154B2 (de) | 1,4-dihydro-1,8-naphthyridinderivate und ein verfahren zu ihrer herstellung | |
| AT220157B (de) | Verfahren zur Herstellung neuer Ester der Nicotinsäure | |
| AT391866B (de) | Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine | |
| DE2238304C3 (de) | (Choleretisch wirksame) Ester bzw. Salze von Dehydrocholsäure, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate | |
| AT229496B (de) | Verfahren zur Darstellung des neuen Nicotinsäureesters des Dihydrohydroxycodeinons | |
| DE2324993C3 (de) | 4'-dehydro-oleandrin, verfahren zu dessen herstellung sowie ein diese verbindung enthaltendes pharmazeutisches praeparat | |
| DE927269C (de) | Verfahren zur Herstellung neuer Derivate des 2-Mercapto-naphthimidazols | |
| AT239968B (de) | Verfahren zur Herstellung von neuen Nicotinsäureestern | |
| DE2402231A1 (de) | Verfahren zur herstellung von benorilat | |
| AT222647B (de) | Verfahren zur Herstellung neuer Acylverbindungen des 4-Aminophenols | |
| DE881795C (de) | Verfahren zur Herstellung von Cholinabkoemmlingen | |
| DE698546C (de) | Verfahren zur Herstellung eines Amidins | |
| AT223330B (de) | Verfahren zur Herstellung von neuen Morphin-bis-pyridincarbonsäureestern | |
| DE479669C (de) | Verfahren zur Herstellung von Verbindungen der Dialkyl- und Arylalkylbarbitursaeuren | |
| DE908020C (de) | Verfahren zur Herstellung von 2-Amino-pyridinverbindungen | |
| AT221501B (de) | Verfahren zur Herstellung der neuen 4-Chlor-3-sulfamyl-benzoesäure und deren Alkalisalze | |
| DE1445417A1 (de) | Verfahren zur Herstellung von neuen Hexitestern der Nikotinsaeure | |
| AT239969B (de) | Verfahren zur Herstellung von neuen Estern der Nicotinsäure | |
| AT254873B (de) | Verfahren zur Herstellung des neuen O-Nicotinoylcholinchlorid-Hydrochlorids, bzw. dessen Base | |
| CH348159A (de) | Verfahren zur Herstellung von neuen Nikotinsäureestern | |
| AT222119B (de) | Verfahren zur Herstellung des neuen N-(p-Äthoxy-phenyl)-isonicotinsäureamides | |
| DE3433188A1 (de) | Ursodesoxycholsaeure-derivat, verfahren zu seiner herstellung und solch ein derivat enthaltende pharmazeutische zusammensetzung | |
| CH360063A (de) | Verfahren zur Herstellung von Salpetersäureestern von Carbonsäure-oxyalkylamiden | |
| CH293297A (de) | Verfahren zur Herstellung eines neuen Esters. | |
| DE1145617B (de) | Verfahren zur Herstellung von Trialkoxybenzoesaeureestern des 3-Chlor-10-{3-[4-(ª‰-oxyaethyl)-piperazino]-propyl}-phenthiazins |